Integrity Advisory’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,687	Closed	-$241K	–	78
2022 Q3	$241K	Sell	3,687 -1,387	-27%	-$90.7K	0.22%	64
2022 Q2	$308K	Buy	5,074 +275	+6%	+$16.7K	0.3%	54
2022 Q1	$301K	Buy	+4,799	New	+$301K	0.3%	60